KMI Diagnostics

KMI Diagnostics, Inc. operates as a leading provider of diagnostic lab testing services to clinics, contract research organizations (CROs), university groups, and the private biomedical industry. Founded in 2005 by Mark Kowal, the company initially focused on offering customized test services to private and university-based researchers. Recognizing a gap in the medical research community, KMI Diagnostics tailored its services to meet the individual needs of researchers who preferred to outsource their sample testing. Today, KMI Diagnostics continues to provide individualized services while having expanded to become a CLIA Certified facility, offering clinical lab testing services for clinics and physicians in addition to its flagship services in the medical research sector. The company's diagnostic lab testing services are trusted by clinics and healthcare providers for their high quality and reliable lab diagnostics. Meanwhile, its status as a CLIA-certified diagnostic lab is highly valued by researchers, often being a requirement for research clients needing dependable data. The company has a solid track record of delivering high-quality laboratory data to prestigious institutions, including Ivy League universities, leading hospitals, and government research programs across the United States. KMI Diagnostics has also built lasting partnerships with individual healthcare providers and clinics, meeting their needs for reliable serology, salivary, and urine test results. As it continues to grow, KMI Diagnostics remains poised to further expand its influence and capabilities within the Biotechnology and Health Care industries, catering to the evolving needs of the medical and research communities. In summary, KMI Diagnostics is a dynamic and established player in the diagnostic lab testing space, poised for continued growth and impact within the healthcare and biotechnology sectors.